Fanconi's anaemia is an autosomal recessive disorder in which patients develop hypoplastic anaemia. It is usually associated with diverse congenital abnormalities which may include skeletal deformities, skin hyperpigmentation, growth retardation, deafness, and genital, ocular, renal, and cardiac defects.1
Patients also have an abnormally high risk of developing malignant disease, particularly acute myelomonocytic leukaemia. 2 One of the most striking features of Fanconi's anaemia is the variation between symptoms and the course of the disease in different patients. Such variation may occur among unrelated cases, but also between sibs.3 4 Patients also show wide variation in the age of onset of haematological symptoms and in the course of the disease.56 Such variation, particularly in the absence of congenital abnormalities or other affected sibs, can lead to difficulties in the diagnosis. 7 Many authors have shown that cultured lymphocytes from Fanconi's anaemia patients display abnormally high levels of chromosome breakage, both spontaneously and following treatment with bifunctional alkylating agents such as mitomycin C8 (MMC) or diepoxybutane (DEB).9 These features have been used extensively as aids in the Received for publication 5 October 1983. Accepted for publication 10 October 1983. diagnosis of Fanconi's anaemia. However, some authors claim that certain patients with typical clinical manifestations of Fanconi's anaemia show normal levels of spontaneous and induced lymphocyte chromosome breakage.410 Conversely, abnormally high levels of spontaneous and induced chromosome breakage have been shown in some patients not judged to have the necessary clinical symptoms for a diagnosis of the disease.7 All these findings suggest that Fanconi's anaemia may be heterogeneous with regard to chromosomal instability. However, since the diagnosis is complicated by both variation in clinical symptoms and the existence of similar symptoms in some other disorders, great care is obviously necessary when diagnosing the disease in cytogenetically normal patients.
In the present study lymphocytes from nine previously unreported patients with Fanconi's anaemia, ascertained because of their clinical symptoms, were compared in order to investigate whether there was any consistent inter-patient variation in the levels of spontaneous and induced chromosome breakage. The usefulness of cytogenetic methods in the diagnosis of the disease and in the detection of heterozygotes is discussed. 
